Please login to the form below

Not currently logged in
Email:
Password:

Advent

This page shows the latest Advent news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s flat sales focus investor attention on M&A

Pfizer’s flat sales focus investor attention on M&A

In the last few weeks Sanofi has sold its European generics business to Advent, GlaxoSmithKline divested its rare disease unit to start-up Orchard Therapeutics after buying Novartis out of a

Latest news

More from news
Approximately 3 fully matching, plus 91 partially matching documents found.

Latest Intelligence

  • Behaviour change: what is the buzz all about? Behaviour change: what is the buzz all about?

    The advent of the ‘informed patient’ for whom social media, in particular, has provided a voice, means that patients have become more central – a positive trend that looks set to increase

  • Cancer care – the power of new technologies Cancer care – the power of new technologies

    Generally, new medicines and treatment approaches are offering renewed hope for cancer patients and the advent of innovative digital technologies is starting to disrupt clinical practice, presenting new ways of driving

  • Reaching the new influencers Reaching the new influencers

    Right now, we’re living through healthcare’s age of accelerations - as evidenced by advances in everything from biotechnology and stem cell research to machine learning and the advent (and approvals)

  • Cancer in The Information Age: are we illuminated or inundated? Cancer in The Information Age: are we illuminated or inundated?

    Personalised vs personal medicine. Data and information have already proved fruitful in the clinic, yielding the advent of personalised cancer medicine,.

  • No incentive for a cure No incentive for a cure

    the health of motor neurons. The advent of these ‘regenerative medicines’ - often highly tailored to the patient’s specific genetic make-up - is a genuine revolution in healthcare.

More from intelligence
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics